# Merz Pharma GmbH & Co., KGaA – FDA Inspection, Jul 4, 2017

Source: https://www.keypedia.com/records/fda_inspections/merz-pharma-gmbh-co-kgaa/c753b773-c4fd-403c-8c66-d824651e0b65
Source feed: FDA_Inspections

> FDA inspection 1021141 of Merz Pharma GmbH & Co., KGaA, July 04, 2017. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021141
- Company Name: Merz Pharma GmbH & Co., KGaA
- Inspection Date: 2017-07-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1250812 - 2022-06-29
- [FDA Inspection 1088213 - 2019-03-14](https://www.keypedia.com/records/fda_inspections/merz-pharma-gmbh-co-kgaa/1e9f4d3a-ae07-4492-817b-3e90a004f18c)
- FDA Inspection 945417 - 2015-09-15
- FDA Inspection 853048 - 2013-09-25
- FDA Inspection 773481 - 2011-10-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/lynda-l-perry/7a3fa780-f0f4-4e8b-9617-f708ffd46668)
- [Stephanie A. Slater](https://www.keypedia.com/people/stephanie-a-slater/f356e65c-3398-4688-8b86-4dcd4b9ae83b)

Company: https://www.keypedia.com/companies/merz-pharma-gmbh-co-kgaa/758203de-10f2-4cff-a0ca-d3b1152277c0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
